(Q40789611)

23 September 2017

title

Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma (English)

1 reference

23 September 2017

0 references

1 reference

5

1 reference

23 September 2017

L Weinrib

1

1 reference

23 September 2017

J H Li

series ordinal

2

1 reference

23 September 2017

J Donovan

series ordinal

3

1 reference

23 September 2017

D Huang

series ordinal

4

1 reference

23 September 2017

publication date

1 May 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

352-360

1 reference

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Adenovirus‐mediated gene transfer of wild‐type p53 results in melanoma cell apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Characterization of a new EBV-associated nasopharyngeal carcinoma cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

The Mechanism of Action of Antitumor Platinum Compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Safety evaluation of Ad5CMV-p53 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700319

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700319

1 reference

Dimensions Publication ID

23 September 2017

1022680126

0 references

1 reference